Motivated to advance the clinical integration of genomics and precision medicine through the development of robust evidence of value (outcomes/cost) to patients, health systems and payers. More than 25 years of experience in the field of health economics and outcomes research in both non-profit and for-profit settings as a researcher, educator, consultant and department head. Successful track record of engaging stakeholders to address complex barriers to clinical integration of new drugs and diagnostics, particularly coverage and reimbursement challenges. Currently focused on advising biopharmaceutical and medical technology companies develop evidence to support coverage and clinical adoption of innovative technologies.
SVP, Commercial Strategy & Market Access at Veranex
Fellowship, Genome Ethics, Law & Policy